Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection

Bartsch JW, Wildeboer D, Koller G, Naus S, Rittger A, Moss ML, Minai Y, Jockusch H (2010)
J Neurosci 30(36): 12210-12218.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Bartsch, Joerg W.; Wildeboer, Dirk; Koller, Garrit; Naus, Silvia; Rittger, Andrea; Moss, Marcia L.; Minai, Yuji; Jockusch, HaraldUniBi
Abstract / Bemerkung
Tumor necrosis factor alpha (TNF-alpha) is a potent cytokine in neurodegenerative disorders, but its precise role in particular brain disorders is ambiguous. In motor neuron (MN) disease of the mouse, exemplified by the model wobbler (WR), TNF-alpha causes upregulation of the metalloprotease-disintegrin ADAM8 (A8) in affected brain regions, spinal cord, and brainstem. The functional role of A8 during MN degeneration in the wobbler CNS was investigated by crossing WR with A8-deficient mice: a severely aggravated neuropathology was observed for A8-deficient WR compared with WRA8(+/-) mice, judged by drastically reduced survival [ 7 vs 81% survival at postnatal day 50 (P50)], accelerated force loss in the forelimbs, and terminal akinesis. In vitro protease assays using soluble A8 indicated specific cleavage of a TNF-alpha receptor 1 (p55 TNF-R1) but not a TNF-R2 peptide. Cleavage of TNF-R1 was confirmed in situ, because levels of soluble TNF-R1 were increased in spinal cords of standard WR compared with wild-type mice but not in A8-deficient WR mice. In isolated primary neurons and microglia, TNF-alpha-induced TNF-R1 shedding was dependent on the A8 gene dosage. Furthermore, exogenous TNF-alpha showed higher toxicity for cultured neurons from A8-deficient than for those from wild-type mice, demonstrating that TNF-R1 shedding by A8 is neuroprotective. Our results indicate an essential role for ADAM8 in modulating TNF-alpha signaling in CNS diseases: a feedback loop integrating TNF-alpha, ADAM8, and TNF-R1 shedding as a plausible mechanism for TNF-alpha mediated neuroprotection in situ and a rationale for therapeutic intervention.
J Neurosci
Page URI


Bartsch JW, Wildeboer D, Koller G, et al. Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection. J Neurosci. 2010;30(36):12210-12218.
Bartsch, J. W., Wildeboer, D., Koller, G., Naus, S., Rittger, A., Moss, M. L., Minai, Y., et al. (2010). Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection. J Neurosci, 30(36), 12210-12218. https://doi.org/10.1523/JNEUROSCI.1520-10.2010
Bartsch, J. W., Wildeboer, D., Koller, G., Naus, S., Rittger, A., Moss, M. L., Minai, Y., and Jockusch, H. (2010). Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection. J Neurosci 30, 12210-12218.
Bartsch, J.W., et al., 2010. Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection. J Neurosci, 30(36), p 12210-12218.
J.W. Bartsch, et al., “Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection”, J Neurosci, vol. 30, 2010, pp. 12210-12218.
Bartsch, J.W., Wildeboer, D., Koller, G., Naus, S., Rittger, A., Moss, M.L., Minai, Y., Jockusch, H.: Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection. J Neurosci. 30, 12210-12218 (2010).
Bartsch, Joerg W., Wildeboer, Dirk, Koller, Garrit, Naus, Silvia, Rittger, Andrea, Moss, Marcia L., Minai, Yuji, and Jockusch, Harald. “Tumor Necrosis Factor-alpha (TNF-alpha) Regulates Shedding of TNF-alpha Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection”. J Neurosci 30.36 (2010): 12210-12218.

25 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Effects of TNF receptor blockade on in vitro cell survival and response to negative energy balance in dairy cattle.
Martel CA, Mamedova LK, Minton JE, Garcia M, Legallet C, Bradford BJ., J Anim Sci Biotechnol 9(), 2018
PMID: 29344353
HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.
de la Fuente Revenga M, Ibi D, Saunders JM, Cuddy T, Ijaz MK, Toneatti R, Kurita M, Holloway T, Shen L, Seto J, Dozmorov MG, González-Maeso J., Neuroscience 388(), 2018
PMID: 30025863
Inducible expression of A Disintegrin and Metalloproteinase 8 in chronic periodontitis and gingival epithelial cells.
Aung WPP, Chotjumlong P, Pata S, Montreekachon P, Supanchart C, Khongkhunthian S, Sastraruji T, Krisanaprakornkit S., J Periodontal Res 52(3), 2017
PMID: 27859260
Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progression.
Theodorou K, van der Vorst EPC, Gijbels MJ, Wolfs IMJ, Jeurissen M, Theelen TL, Sluimer JC, Wijnands E, Cleutjens JP, Li Y, Jansen Y, Weber C, Ludwig A, Bentzon JF, Bartsch JW, Biessen EAL, Donners MMPC., Sci Rep 7(1), 2017
PMID: 28916789
γ-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling.
Chhibber-Goel J, Coleman-Vaughan C, Agrawal V, Sawhney N, Hickey E, Powell JC, McCarthy JV., J Biol Chem 291(11), 2016
PMID: 26755728
The ADAMs family of proteases as targets for the treatment of cancer.
Mullooly M, McGowan PM, Crown J, Duffy MJ., Cancer Biol Ther 17(8), 2016
PMID: 27115328
ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.
Dreymueller D, Uhlig S, Ludwig A., Am J Physiol Lung Cell Mol Physiol 308(4), 2015
PMID: 25480335
ADAM8 as a drug target in pancreatic cancer.
Schlomann U, Koller G, Conrad C, Ferdous T, Golfi P, Garcia AM, Höfling S, Parsons M, Costa P, Soper R, Bossard M, Hagemann T, Roshani R, Sewald N, Ketchem RR, Moss ML, Rasmussen FH, Miller MA, Lauffenburger DA, Tuveson DA, Nimsky C, Bartsch JW., Nat Commun 6(), 2015
PMID: 25629724
Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
Miller MA, Moss ML, Powell G, Petrovich R, Edwards L, Meyer AS, Griffith LG, Lauffenburger DA., Sci Rep 5(), 2015
PMID: 26477568
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
Romagnoli M, Mineva ND, Polmear M, Conrad C, Srinivasan S, Loussouarn D, Barillé-Nion S, Georgakoudi I, Dagg Á, McDermott EW, Duffy MJ, McGowan PM, Schlomann U, Parsons M, Bartsch JW, Sonenshein GE., EMBO Mol Med 6(2), 2014
PMID: 24375628
N-glycosylation regulates ADAM8 processing and activation.
Srinivasan S, Romagnoli M, Bohm A, Sonenshein GE., J Biol Chem 289(48), 2014
PMID: 25336660
Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush.
Mac Nair CE, Fernandes KA, Schlamp CL, Libby RT, Nickells RW., J Neuroinflammation 11(), 2014
PMID: 25407441
Elevated levels of a disintegrin and metalloproteinase 8 in gingival crevicular fluid of patients with periodontal diseases.
Khongkhunthian S, Techasatian P, Supanchart C, Bandhaya P, Montreekachon P, Thawanaphong S, Krisanaprakornkit S., J Periodontol 84(4), 2013
PMID: 22612366
Loss of vps54 function leads to vesicle traffic impairment, protein mis-sorting and embryonic lethality.
Karlsson P, Droce A, Moser JM, Cuhlmann S, Padilla CO, Heimann P, Bartsch JW, Füchtbauer A, Füchtbauer EM, Schmitt-John T., Int J Mol Sci 14(6), 2013
PMID: 23708095
(-)-Epigallocatechin gallate inhibits TNF-α-induced PAI-1 production in vascular endothelial cells.
Cao Y, Wang D, Wang X, Zhang J, Shan Z, Teng W., J Cardiovasc Pharmacol 62(5), 2013
PMID: 23921304
The role of ADAM-mediated shedding in vascular biology.
Dreymueller D, Pruessmeyer J, Groth E, Ludwig A., Eur J Cell Biol 91(6-7), 2012
PMID: 22138087
Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.
Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q., J Biol Chem 287(20), 2012
PMID: 22447932
Inflammatory cytokines in experimental and human stroke.
Lambertsen KL, Biber K, Finsen B., J Cereb Blood Flow Metab 32(9), 2012
PMID: 22739623
Common variation in the ADAM8 gene affects serum sADAM8 concentrations and the risk of myocardial infarction in two independent cohorts.
Raitoharju E, Seppälä I, Levula M, Kuukasjärvi P, Laurikka J, Nikus K, Huovila AP, Oksala N, Klopp N, Illig T, Laaksonen R, Karhunen PJ, Viik J, Lehtinen R, Pelto-Huikko M, Tarkka M, Kähönen M, Lehtimäki T., Atherosclerosis 218(1), 2011
PMID: 21640993
ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
Moss ML, Powell G, Miller MA, Edwards L, Qi B, Sang QX, De Strooper B, Tesseur I, Lichtenthaler SF, Taverna M, Zhong JL, Dingwall C, Ferdous T, Schlomann U, Zhou P, Griffith LG, Lauffenburger DA, Petrovich R, Bartsch JW., J Biol Chem 286(47), 2011
PMID: 21956108

38 References

Daten bereitgestellt von Europe PubMed Central.

Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse.
Bigini P, Repici M, Cantarella G, Fumagalli E, Barbera S, Cagnotto A, De Luigi A, Tonelli R, Bernardini R, Borsello T, Mennini T., Neurobiol. Dis. 29(3), 2007
PMID: 18201889
Tumor necrosis factor-alpha converting enzyme.
Black RA., Int. J. Biochem. Cell Biol. 34(1), 2002
PMID: 11733179
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP., Nature 385(6618), 1997
PMID: 9034190
TNF-R1 signaling: a beautiful pathway.
Chen G, Goeddel DV., Science 296(5573), 2002
PMID: 12040173
Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding.
Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, Rouhani FN, Miskinis D, Levine SJ., J. Clin. Invest. 110(4), 2002
PMID: 12189246
TNFRSF1A mutations and autoinflammatory syndromes.
Galon J, Aksentijevich I, McDermott MF, O'Shea JJ, Kastner DL., Curr. Opin. Immunol. 12(4), 2000
PMID: 10899034
The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL., Medicine (Baltimore) 81(5), 2002
PMID: 12352631
Wobbler, a mutation affecting motoneuron survival and gonadal functions in the mouse, maps to proximal chromosome 11.
Kaupmann K, Simon-Chazottes D, Guenet JL, Jockusch H., Genomics 13(1), 1992
PMID: 1349581
Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.
Kelly K, Hutchinson G, Nebenius-Oosthuizen D, Smith AJ, Bartsch JW, Horiuchi K, Rittger A, Manova K, Docherty AJ, Blobel CP., Dev. Dyn. 232(1), 2005
PMID: 15580619
ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.
Koller G, Schlomann U, Golfi P, Ferdous T, Naus S, Bartsch JW., Curr. Pharm. Des. 15(20), 2009
PMID: 19601829
ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice.
Mahoney ET, Benton RL, Maddie MA, Whittemore SR, Hagg T., J. Comp. Neurol. 512(2), 2009
PMID: 19003792
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.
McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O'Shea JJ, Kastner DL., Cell 97(1), 1999
PMID: 10199409
Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF.
Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM., Science 265(5175), 1994
PMID: 8066451
The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.
Mohan MJ, Seaton T, Mitchell J, Howe A, Blackburn K, Burkhart W, Moyer M, Patel I, Waitt GM, Becherer JD, Moss ML, Milla ME., Biochemistry 41(30), 2002
PMID: 12135369
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD., Nature 385(6618), 1997
PMID: 9034191
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
Naus S, Reipschlager S, Wildeboer D, Lichtenthaler SF, Mitterreiter S, Guan Z, Moss ML, Bartsch JW., Biol. Chem. 387(3), 2006
PMID: 16542157
Sensitization of spinal cord nociceptive neurons with a conjugate of substance P and cholera toxin.
Caudle RM, Mannes AJ, Keller J, Perez FM, Suckow SK, Neubert JK., BMC Neurosci 8(), 2007
PMID: 17493276
Defining "neuroinflammation".
O'Callaghan JP, Sriram K, Miller DB., Ann. N. Y. Acad. Sci. 1139(), 2008
PMID: 18991877
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM., Neurobiol. Aging 24(8), 2003
PMID: 14643377
An essential role for ectodomain shedding in mammalian development.
Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA., Science 282(5392), 1998
PMID: 9812885
Constitutive shedding of both p55 and p75 murine TNF receptors in vivo.
Pinckard JK, Sheehan KC, Arthur CD, Schreiber RD., J. Immunol. 158(8), 1997
PMID: 9103455
Spatiotemporal progression of neurodegeneration and glia activation in the wobbler neuropathy of the mouse.
Rathke-Hartlieb S, Schmidt VC, Jockusch H, Schmitt-John T, Bartsch JW., Neuroreport 10(16), 1999
PMID: 10599854
Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.
Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA., J. Biol. Chem. 275(19), 2000
PMID: 10799547
The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.
Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJ, Lambert M, Skelton L, Jockusch H, Bartsch JW., J. Biol. Chem. 277(50), 2002
PMID: 12372841
Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse.
Schmitt-John T, Drepper C, Mussmann A, Hahn P, Kuhlmann M, Thiel C, Hafner M, Lengeling A, Heimann P, Jones JM, Meisler MH, Jockusch H., Nat. Genet. 37(11), 2005
PMID: 16244655
Divergent roles for tumor necrosis factor-alpha in the brain.
Sriram K, O'Callaghan JP., J Neuroimmune Pharmacol 2(2), 2007
PMID: 18040839
ERK and cell death: ERK1/2 in neuronal death.
Subramaniam S, Unsicker K., FEBS J. 277(1), 2009
PMID: 19843173
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.
Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, Valable S, Ghezzi P, Quackenbush J, Brines M, Cerami A, Probert L., Proc. Natl. Acad. Sci. U.S.A. 105(16), 2008
PMID: 18413601
Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.
Xanthoulea S, Pasparakis M, Kousteni S, Brakebusch C, Wallach D, Bauer J, Lassmann H, Kollias G., J. Exp. Med. 200(3), 2004
PMID: 15289505


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 20826683
PubMed | Europe PMC

Suchen in

Google Scholar